SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending as traders discuss its low float and potential for a significant breakout, drawing comparisons to other low-float stocks. Community members highlight the possibility of a short squeeze and anticipation for news catalysts, driving speculation about a potential run to higher price levels. Traders are closely monitoring key price levels as potential triggers for further upward momentum.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences ($GLSI) is trending due to positive buzz surrounding its FLAMINGO-01 trial and anticipation of potential news. The community highlights a preliminary analysis showing a significant recurrence rate reduction, fueling excitement. Discussions also revolve around the high short borrow rate and potential for a short squeeze, with some expecting major announcements soon.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential cannabis rescheduling, driven by reports of executive action and Supreme Court involvement. Community members are weighing the potential impacts on the sector, discussing possible rallies and short squeezes while considering potential volatility and the long-term implications for cannabis businesses. The focus remains on upcoming announcements and their effects on market dynamics.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending as chatter around defense contracts and the "Golden Dome" project heats up. The community speculates about potential benefits from increased defense spending and upcoming contracts. Some are also discussing the potential for a short squeeze.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

KYTX is trending as investors await Phase 2 trial results for KYV-101 in stiff person syndrome, expected imminently, with some speculating about positive news catalysts before year-end. Community chatter highlights the potential for a significant breakout, noting institutional backing and a potentially undervalued stock price relative to cash on hand. Some analysts have recently updated their rating for KYTX to Overweight.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as the community discusses the potential for a strategic transaction, fueled by the recent COO promotion and Barclays remaining as advisor.  Discussion is also focused on the upcoming earnings report and potential catalysts such as China NRDL inclusion.  Community members are analyzing the company's financial health, revenue potential, and patent landscape.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is trending as investors assess its potential in the AI sector following a recent partnership announcement; the community is actively discussing the implications of this collaboration and its impact on ARM's growth trajectory. Recent analyst ratings and price target adjustments are also fueling the conversation around the stock's valuation. However, some traders note that ARM's stock movement can be manipulated due to its low float, making it a risky play.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

ARBK is trending due to a potential short squeeze amplified by its nano float and recent reverse stock split, attracting both bullish and bearish sentiments. Traders are actively discussing its high volatility, low price, and the possibility of a dead cat bounce, with some comparing it to other high-potential squeeze candidates. The broader context includes its restructuring to avoid insolvency, delisting from the London Stock Exchange, and correlation with Bitcoin's movements, all contributing to the intense community debate.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending amid discussions around a potential acquisition of cybersecurity firm Armis, with community members weighing the strategic implications of expanding its security offerings. Keybanc's recent underweight rating is also contributing to the conversation. Additionally, the stock's technical indicators, including RSI and moving averages, are being analyzed for potential trade opportunities.

Compass, Inc. engages in the provision of an online real estate platform. Its platform provides an integrated suite of software for customer relationship management, marketing, client service, operations and other critical functionality, as well as brokerage services and adjacent services. The company was founded by Ori Allon and Robert Reffkin in 2012 and is headquartered in New York, NY.

Compass Inc - Ordinary Shares - Class A

COMP is trending as investors discuss its potential for growth in the mid-tier and luxury real estate markets, particularly with global expansion and strategic acquisitions being key talking points. Bullish sentiment is emerging, with some anticipating a breakout above the $11 resistance level, although overbought conditions indicated by high RSI values and recent analyst rating changes warrant caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea

GSK wins FDA approval for Blujepa, a new oral antibiotic treatment option for uncomplicated urogenital gonorrhea.

Steven Lefkowitz Sells 40,000 Shares of CorMedix (NASDAQ:CRMD) Stock

CorMedix Inc (NASDAQ:CRMD - Get Free Report) Director Steven Lefkowitz sold 40,000 shares of CorMedix stock in a transaction dated Tuesday, December 9th. The shares were sold at an average price of...

GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer

GSK gains FDA Orphan Drug Designation for risvutatug rezetecan, adding momentum to its fast-advancing solid-tumor pipeline.

CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock?

CorMedix surges on strong DefenCath uptake as sales climb while the Melinta acquisition expands and diversifies its commercial portfolio.

Roche's Breast Cancer Drug Cuts Risk of Death by 30% in Phase III

RHHBY's giredestrant cuts the risk of invasive disease recurrence or death by 30% in phase III, fueling momentum for a next-generation endocrine therapy.

Steven Lefkowitz Implements A Sell Strategy: Offloads $475K In Cormedix Stock

CorMedix (NASDAQ:CRMD) Director Steven Lefkowitz Sells 40,000 Shares

CorMedix Inc (NASDAQ:CRMD - Get Free Report) Director Steven Lefkowitz sold 40,000 shares of the company's stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an...

Agios Awaits Pyrukynd Decision in Thalassemia as FDA Misses Due Date

AGIO faces uncertainty as the FDA misses its Dec. 7 deadline related to the sNDA for Pyrukynd in thalassemia and offers no new timeline.

Does CorMedix (CRMD) Have the Potential to Rally 68.74% as Wall Street Analysts Expect?

The mean of analysts' price targets for CorMedix (CRMD) points to a 68.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CorMedix (CRMD) Upgraded to Strong Buy: Here's What You Should Know

CorMedix (CRMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CRMD
CorMedix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRMD News

CRMDCorMedix Inc